0001683168-22-008706.txt : 20221230 0001683168-22-008706.hdr.sgml : 20221230 20221230160537 ACCESSION NUMBER: 0001683168-22-008706 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221228 FILED AS OF DATE: 20221230 DATE AS OF CHANGE: 20221230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Allen Daniel CENTRAL INDEX KEY: 0001736605 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40699 FILM NUMBER: 221502030 MAIL ADDRESS: STREET 1: 299 PARK AVENUE SOUTH STREET 2: SUITE 90959 CITY: NEW YORK STATE: NY ZIP: 10003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PharmaCyte Biotech, Inc. CENTRAL INDEX KEY: 0001157075 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621772151 STATE OF INCORPORATION: NV FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 BUSINESS PHONE: (917) 595.2850 MAIL ADDRESS: STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 FORMER COMPANY: FORMER CONFORMED NAME: NUVILEX, INC. DATE OF NAME CHANGE: 20090324 FORMER COMPANY: FORMER CONFORMED NAME: EFOODSAFETY COM INC DATE OF NAME CHANGE: 20010808 4 1 ownership.xml X0306 4 2022-12-28 1 0001157075 PharmaCyte Biotech, Inc. PMCB 0001736605 Allen Daniel C/O PHARMACYTE BIOTECH, INC. 3960 HOWARD HUGHES PARKWAY, SUITE 500 LAS VEGAS NV 89169 1 0 0 0 Stock Option (Right to Buy) 2.97 2022-12-28 4 A 0 125000 0 A 2022-12-28 2032-11-14 Common Stock 125000 125000 D The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the "2022 Plan"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022. /s/ Daniel Allen 2022-12-30